To determine the relative importance of p53 deletion and the oncogenic mutation in KRAS in the protection of colon cancer cells from ferroptosis, we monitored ferroptosis in all four cell lines using a fluorescence assay that was based on cellular levels of ferroptosis-inducing lipid radicals. The gene discussed is KRAS; the disease is colonic neoplasm.